Lixian Chang

559 total citations
58 papers, 348 citations indexed

About

Lixian Chang is a scholar working on Hematology, Molecular Biology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Lixian Chang has authored 58 papers receiving a total of 348 indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Hematology, 18 papers in Molecular Biology and 15 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Lixian Chang's work include Acute Myeloid Leukemia Research (24 papers), Acute Lymphoblastic Leukemia research (15 papers) and Hematopoietic Stem Cell Transplantation (11 papers). Lixian Chang is often cited by papers focused on Acute Myeloid Leukemia Research (24 papers), Acute Lymphoblastic Leukemia research (15 papers) and Hematopoietic Stem Cell Transplantation (11 papers). Lixian Chang collaborates with scholars based in China, United States and Switzerland. Lixian Chang's co-authors include Xiaofan Zhu, Congcong Sun, Xiaojuan Chen, Ye Guo, Yao Zou, Yumei Chen, Min Ruan, Yingchi Zhang, Jian‐Jun Feng and Jianfang Chen and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Lixian Chang

51 papers receiving 345 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lixian Chang China 11 179 134 89 51 42 58 348
S. K. China 11 176 1.0× 85 0.6× 105 1.2× 31 0.6× 61 1.5× 23 337
Shaoyan Hu China 10 124 0.7× 176 1.3× 59 0.7× 23 0.5× 31 0.7× 77 325
Catherine Garnett United Kingdom 8 234 1.3× 84 0.6× 66 0.7× 27 0.5× 88 2.1× 13 363
Biljana Jekić Serbia 10 69 0.4× 81 0.6× 102 1.1× 34 0.7× 62 1.5× 42 348
Huyong Zheng China 11 111 0.6× 144 1.1× 163 1.8× 101 2.0× 28 0.7× 36 347
Alexandre Bazinet United States 9 221 1.2× 155 1.2× 56 0.6× 16 0.3× 87 2.1× 38 365
Chantal Fossat France 10 128 0.7× 66 0.5× 81 0.9× 20 0.4× 41 1.0× 16 283
Anup J. Devasia India 11 254 1.4× 115 0.9× 50 0.6× 24 0.5× 42 1.0× 79 392
Shinsuke Hirabayashi Japan 9 134 0.7× 65 0.5× 48 0.5× 22 0.4× 43 1.0× 28 220
Ci Pan China 14 96 0.5× 70 0.5× 157 1.8× 109 2.1× 29 0.7× 37 405

Countries citing papers authored by Lixian Chang

Since Specialization
Citations

This map shows the geographic impact of Lixian Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lixian Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lixian Chang more than expected).

Fields of papers citing papers by Lixian Chang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lixian Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lixian Chang. The network helps show where Lixian Chang may publish in the future.

Co-authorship network of co-authors of Lixian Chang

This figure shows the co-authorship network connecting the top 25 collaborators of Lixian Chang. A scholar is included among the top collaborators of Lixian Chang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lixian Chang. Lixian Chang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Yaqin, Lixian Chang, Beibei Zhao, et al.. (2025). Venetoclax plus Modified-Intensity Idarubicin and Cytarabine Treatment as First-Line Treatment for Newly Diagnosed Pediatric Acute Myeloid Leukemia. Clinical Cancer Research. 31(13). 2608–2616.
2.
Qi, Ben-Quan, Lixian Chang, Wenyu Yang, et al.. (2024). Early Detection of Molecular Residual Disease and Risk Stratification for Children with Acute Myeloid Leukemia via Circulating Tumor DNA. Clinical Cancer Research. 30(6). 1143–1151. 5 indexed citations
3.
Chang, Lixian, Beibei Zhao, Yi Zheng, et al.. (2024). Efficacy, Safety, and Population Pharmacokinetics of Eltrombopag in Children with Different Severities of Aplastic Anemia. The Journal of Clinical Pharmacology. 64(8). 932–943.
4.
Cheng, Hua, et al.. (2024). A Fruit and Vegetable Recognition Method based on AugMSR-CNN. 93–97. 1 indexed citations
5.
Zhang, Jingliao, Tianfeng Liu, Lixian Chang, et al.. (2023). Single-cell analysis highlights a population of Th17-polarized CD4+ naïve T cells showing IL6/JAK3/STAT3 activation in pediatric severe aplastic anemia. Journal of Autoimmunity. 136. 103026–103026. 14 indexed citations
6.
Chang, Lixian, Jingliao Zhang, Binghang Liu, et al.. (2023). An investigation of long-term outcome of rabbit anti-thymocyte globulin and cyclosporine therapy for pediatric severe aplastic anemia. SHILAP Revista de lepidopterología. 5(3). 180–186.
7.
Liu, Lipeng, Lixian Chang, Xiaojuan Chen, et al.. (2023). Pediatric acute myeloid leukemia and hyperleukocytosis with WBC count greater than 50 × 109/L. International Journal of Hematology. 118(6). 737–744. 1 indexed citations
8.
Liu, Xiaoming, Yao Zou, Li Zhang, et al.. (2022). A Novel Risk Defining System for Pediatric T-Cell Acute Lymphoblastic Leukemia From CCCG-ALL-2015 Group. Frontiers in Oncology. 12. 841179–841179. 6 indexed citations
9.
Liu, Lipeng, Lixian Chang, Xiaojuan Chen, et al.. (2022). Pediatric non–Down’s syndrome acute megakaryoblastic leukemia patients in China: A single center's real-world analysis. Frontiers in Oncology. 12. 940725–940725. 4 indexed citations
10.
Liu, Lipeng, Meihui Yi, Luyang Zhang, et al.. (2022). Droplet digital PCR for genetic mutations monitoring predicts relapse risk in pediatric acute myeloid leukemia. International Journal of Hematology. 116(5). 669–677. 4 indexed citations
11.
Chang, Lixian, Li Zhang, Yang Wan, et al.. (2022). Phenotypic and genotypic correlation evaluation of 148 pediatric patients with Fanconi anemia in a Chinese rare disease cohort. Clinica Chimica Acta. 539. 41–49. 2 indexed citations
12.
Liu, Fang, Lixian Chang, Lipeng Liu, et al.. (2021). Combination of umbilical cord mesenchymal stem cells and standard immunosuppressive regimen for pediatric patients with severe aplastic anemia. BMC Pediatrics. 21(1). 102–102. 10 indexed citations
13.
Chang, Lixian, Yuwen Chen, Li Tang, et al.. (2021). Analysis of peripherally inserted central catheter-related complications: a retrospective cohort study of 2,974 children with blood diseases in a single center of China. Annals of Palliative Medicine. 10(3). 2971–2978. 7 indexed citations
14.
Liu, Xiaoming, Yao Zou, Min Ruan, et al.. (2020). Pediatric Acute Lymphoblastic Leukemia Patients Exhibit Distinctive Alterations in the Gut Microbiota. Frontiers in Cellular and Infection Microbiology. 10. 558799–558799. 40 indexed citations
15.
Sun, Congcong, et al.. (2019). The study of METTL3 and METTL14 expressions in childhood ETV6/RUNX1‐positive acute lymphoblastic leukemia. Molecular Genetics & Genomic Medicine. 7(10). e00933–e00933. 17 indexed citations
16.
17.
Wan, Yang, Xiaojuan Chen, Min Ruan, et al.. (2016). Clinical features, mutations and treatment of 104 patients of Diamond-Blackfan anemia in China: a single-center retrospective study. International Journal of Hematology. 104(4). 430–439. 7 indexed citations
18.
Zhang, Jiayuan, Li Zhang, Lixian Chang, et al.. (2015). [Genotype analysis and telomere length measure in patients with dyskeratosis congenita].. PubMed. 23(1). 212–6. 2 indexed citations
19.
Chen, Xiaojuan, Yao Zou, Lixian Chang, et al.. (2015). Prediction of outcomes by early treatment responses in childhood T-cell acute lymphoblastic leukemia: a retrospective study in China. BMC Pediatrics. 15(1). 80–80. 14 indexed citations
20.
Zhang, Jingliao, Lixian Chang, Yingchi Zhang, et al.. (2015). Mutation analysis of Chinese sporadic congenital sideroblastic anemia by targeted capture sequencing. Journal of Hematology & Oncology. 8(1). 55–55. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by S. K. Breakdown of academic impact, for papers by Shaoyan Hu Breakdown of academic impact, for papers by Catherine Garnett Breakdown of academic impact, for papers by Biljana Jekić Breakdown of academic impact, for papers by Huyong Zheng Breakdown of academic impact, for papers by Alexandre Bazinet Breakdown of academic impact, for papers by Chantal Fossat Breakdown of academic impact, for papers by Anup J. Devasia Breakdown of academic impact, for papers by Shinsuke Hirabayashi Breakdown of academic impact, for papers by Ci Pan
Rankless by CCL
2026